Innovation
State-backed ALX Oncology raises $63.2m in public offering
The Ireland Strategic Investment Fund (ISIF) has a minority interest in the Nasdaq-listed biotech company through its partnership with Lightstone Ventures
The Ireland Strategic Investment Fund (ISIF) has a minority interest in the Nasdaq-listed biotech company through its partnership with Lightstone Ventures